Molecular Genetics & Genomic Medicine
© 2013 John Wiley & Sons Ltd.
Each article is made available under the terms of the Creative Commons Attribution License
Editor-in-Chief: Maximilian Muenke, M.D., Deputy Editor: Suzanne Hart, Ph.D.
Online ISSN: 2324-9269
Publishers' Note: Wiley Announces Launch of a new Open Access journal
The completion of the Human Genome Project has led to advances in exome analysis and rapid, affordable whole-genome sequencing, resulting in profound changes in human, medical, and molecular genetics research. Next-generation molecular diagnostic methods are enabling investigators to find novel human disease-related genes and common disease-associated variants more rapidly. Improved understanding of the biological bases of inherited disease and common disorders can lead to translational research and development of unforeseen treatments and cures.
Launched in Fall 2012, Molecular Genetics & Genomic Medicine(MGGM) is a peer reviewed journal for rapid dissemination of high-quality research in all areas of human, medical and molecular genetics. Under the leadership of Editor-in-Chief Maximilian Muenke (Bethesda, Maryland, USA), MGGM will publish original research covering molecular, biological, and genomic aspects of gene variation, inherited disorders and birth defects. Reports of novel disease genes, functional studies of genetic variants, genotype-phenotype studies, genomic analysis of rare and common inherited disorders, and molecular and clinical diagnostic methods will be considered.
MGGM publishes original research, reviews, research methods papers, invited editorials, and commentaries. Rigorous peer review and evaluation is overseen by Dr. Muenke, Deputy Editor Suzanne Hart (Bethesda, Maryland, USA), and an international editorial board of experts in diverse areas of human and medical genetics and genomics research.
As with all of Wiley’s peer reviewed Open Access titles, MGGM offers authors a fast route to publication and the ability to share research with the widest possible audience of scientists and professionals. This multidisciplinary journal will appeal to researchers and professionals working in any area of human molecular genetics and medicine.
A number of Wiley's genetics journals support MGGM via the Manuscript transfer program:
|American Journal of Medical Genetics - Part A||Human Mutation|
|American Journal of Medical Genetics - Part B||Genetic Epidemiology|
|Clinical Genetics||Annals of Human Genetics|
The National Human Genome Research Institute and the National Heart, Lung, and Blood Institute have partnered to support the discovery of variant genes underlying Mendelian disorders at three Centers for Mendelian Genomics. Click here for more information.
New Articles Online
We are delighted to announce that MGGM has now published its inaugural issue. All articles are free to read, download and share. Click the button above to access all the articles. Editorial highlights for this issue are MT-CYBmutations in Hypertrophic Cardiomyopathy and Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.
Dr. Max Muenke trained in Pediatrics in his native Germany. He pursued postdoctoral training in Human Genetics at Yale and the University of Pennsylvania and completed a fellowship in Clinical Genetics at the Children’s Hospital of Philadelphia. For the past two decades, the focus of his research has been on the delineation and identification of the underlying causes of craniofacial anomalies in humans. His lab made seminal discoveries in linking Sonic Hedgehog signaling to normal and abnormal brain development in humans and has identified over a dozen genes involved in holoprosencephaly, the most common anomaly of the developing forebrain. His group identified several genes important in craniofacial disorders including the most common craniosynostosis syndrome, now termed Muenke syndrome. More recently, his lab has identified susceptibility loci for the most common behavioral disorder in childhood, Attention-Deficit/Hyperactivity Disorder (ADHD), with further research focused on predicting severity, treatment response, and long-term outcome. Dr. Muenke is also interested in personalized medicine, from understanding rare and common diseases to their treatment and prevention.
Call for Papers
We are delighted to invite you to submit your paper to Molecular Genetics & Genomic Medicine. Papers are welcomed reporting research in the fields of genetic medicine and human molecular genetics. Examples include:
• genomic analysis of inherited disorders
• reports of novel disease-causing mutations and polymorphisms
• functional studies of mutant gene products
• in-depth documentation of genotype-phenotype analysis
• clinical case reports
• novel approaches to clinical diagnosis
• new applications of molecular diagnostic methods
• reports describing genetic databases
• medical bioinformatics
• genetic epidemiology
As an author publishing in MGGM you would benefit from:
• High standard, rigorous peer review
• Rapid publication
• Open access: articles are published under Creative Commons license and authors are the copyright holder
• Fully compliant with open access mandates
• Wide dissemination
• Promotion and publicity of quality research
• Wiley's tradition in publishing excellence in human and medical genetics
Original research papers must report well-conducted research with conclusions supported by the data presented.